Stock ALEMBICLTD ALEMBIC LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Alembic Limited NSE India S.E.

Equities

ALEMBICLTD

INE426A01027

Market Closed - NSE India S.E.
Other stock markets
 07:40:44 2024-04-16 am EDT 		5-day change 1st Jan Change
93.55 INR +2.07% Intraday chart for Alembic Limited -3.56% +3.37%
Apr. 02 Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment MT
Apr. 01 Alembic Limited Announces Cessation of C. P. Buch as an Independent Director CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment
MT
Alembic Limited Announces Cessation of C. P. Buch as an Independent Director
CI
Alembic Pharmaceuticals' Oncology Plant in Gujarat, India Gets One Observation from US FDA
MT
Crisil Keeps AA+ Rating on Alembic Pharmaceuticals' Bank Loans with Stable Outlook
MT
ICRA Affirms AA- Rating on Alembic's Bank Financing; Outlook Stable
MT
Indian shares seen muted tracking broader Asian equities
RE
Alembic Pharmaceuticals Fully Resumes Operations at Manufacturing Unit in South Sikkim, India
MT
Alembic Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q3; EPS Tops Estimates
MT
Alembic Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q3, EPS Beats Estimates
MT
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales
RE
North American Morning Briefing : Jobs Report Tops -2-
DJ
North American Morning Briefing : Microsoft Kicks -2-
DJ
North American Morning Briefing : Stock Futures -2-
DJ
Alembic Pharmaceuticals Expects Operations at Sikkim, India Units to Be Restores in Two Months
MT
Alembic Pharmaceuticals Extends Corporate Guarantee to US-Based Arm to Secure Credit
MT
North American Morning Briefing : Stock Futures -2-
DJ
Alembic Pharmaceuticals Logs Slightly Higher Consolidated Profit in Fiscal Q2; EPS Misses Estimates
MT
India's Alembic Pharma Q2 profit roughly in-line with estimates
RE
North American Morning Briefing : Stocks Look to -2-
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALEMBICLTD Stock
  4. ALEMBICLTD Stock
  5. News Alembic Limited